Report Detail

Pharma & Healthcare Global Nanobody Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4573096
  • |
  • 02 January, 2024
  • |
  • Global
  • |
  • 113 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Nanobody Drug market size was valued at USD 444.5 million in 2022 and is forecast to a readjusted size of USD 1637.9 million by 2029 with a CAGR of 20.5% during review period.
The Global Info Research report includes an overview of the development of the Nanobody Drug industry chain, the market status of Tumor Treatment (Monovalent Nanobodies, Multivalent Nanobodies), Immune Disease Treatment (Monovalent Nanobodies, Multivalent Nanobodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanobody Drug.
Regionally, the report analyzes the Nanobody Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nanobody Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nanobody Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nanobody Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monovalent Nanobodies, Multivalent Nanobodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nanobody Drug market.
Regional Analysis: The report involves examining the Nanobody Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nanobody Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nanobody Drug:
Company Analysis: Report covers individual Nanobody Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nanobody Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Tumor Treatment, Immune Disease Treatment).
Technology Analysis: Report covers specific technologies relevant to Nanobody Drug. It assesses the current state, advancements, and potential future developments in Nanobody Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nanobody Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nanobody Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monovalent Nanobodies
Multivalent Nanobodies
Fusion Nanobodies
Others
Market segment by Application
Tumor Treatment
Immune Disease Treatment
Inflammatory Disease Treatment
Others
Major players covered
Boehringer Ingelheim
Sanofi Company(Ablynx)
Merck KGaA
Jerry Corning
Shenzhen Pregene Biopharma Co
Novamab
PersonGen
Nanjing Legend Biotechnology Co., Ltd.
Taiwan Taisho Pharmaceutical
Yiteng Pharmaceutical
Beijing Shuoxing Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanobody Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nanobody Drug, with price, sales, revenue and global market share of Nanobody Drug from 2018 to 2023.
Chapter 3, the Nanobody Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanobody Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nanobody Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nanobody Drug.
Chapter 14 and 15, to describe Nanobody Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Nanobody Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nanobody Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Monovalent Nanobodies
    • 1.3.3 Multivalent Nanobodies
    • 1.3.4 Fusion Nanobodies
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nanobody Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tumor Treatment
    • 1.4.3 Immune Disease Treatment
    • 1.4.4 Inflammatory Disease Treatment
    • 1.4.5 Others
  • 1.5 Global Nanobody Drug Market Size & Forecast
    • 1.5.1 Global Nanobody Drug Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Nanobody Drug Sales Quantity (2018-2029)
    • 1.5.3 Global Nanobody Drug Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Nanobody Drug Product and Services
    • 2.1.4 Boehringer Ingelheim Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.2 Sanofi Company(Ablynx)
    • 2.2.1 Sanofi Company(Ablynx) Details
    • 2.2.2 Sanofi Company(Ablynx) Major Business
    • 2.2.3 Sanofi Company(Ablynx) Nanobody Drug Product and Services
    • 2.2.4 Sanofi Company(Ablynx) Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sanofi Company(Ablynx) Recent Developments/Updates
  • 2.3 Merck KGaA
    • 2.3.1 Merck KGaA Details
    • 2.3.2 Merck KGaA Major Business
    • 2.3.3 Merck KGaA Nanobody Drug Product and Services
    • 2.3.4 Merck KGaA Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Merck KGaA Recent Developments/Updates
  • 2.4 Jerry Corning
    • 2.4.1 Jerry Corning Details
    • 2.4.2 Jerry Corning Major Business
    • 2.4.3 Jerry Corning Nanobody Drug Product and Services
    • 2.4.4 Jerry Corning Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Jerry Corning Recent Developments/Updates
  • 2.5 Shenzhen Pregene Biopharma Co
    • 2.5.1 Shenzhen Pregene Biopharma Co Details
    • 2.5.2 Shenzhen Pregene Biopharma Co Major Business
    • 2.5.3 Shenzhen Pregene Biopharma Co Nanobody Drug Product and Services
    • 2.5.4 Shenzhen Pregene Biopharma Co Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Shenzhen Pregene Biopharma Co Recent Developments/Updates
  • 2.6 Novamab
    • 2.6.1 Novamab Details
    • 2.6.2 Novamab Major Business
    • 2.6.3 Novamab Nanobody Drug Product and Services
    • 2.6.4 Novamab Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Novamab Recent Developments/Updates
  • 2.7 PersonGen
    • 2.7.1 PersonGen Details
    • 2.7.2 PersonGen Major Business
    • 2.7.3 PersonGen Nanobody Drug Product and Services
    • 2.7.4 PersonGen Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 PersonGen Recent Developments/Updates
  • 2.8 Nanjing Legend Biotechnology Co., Ltd.
    • 2.8.1 Nanjing Legend Biotechnology Co., Ltd. Details
    • 2.8.2 Nanjing Legend Biotechnology Co., Ltd. Major Business
    • 2.8.3 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product and Services
    • 2.8.4 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
  • 2.9 Taiwan Taisho Pharmaceutical
    • 2.9.1 Taiwan Taisho Pharmaceutical Details
    • 2.9.2 Taiwan Taisho Pharmaceutical Major Business
    • 2.9.3 Taiwan Taisho Pharmaceutical Nanobody Drug Product and Services
    • 2.9.4 Taiwan Taisho Pharmaceutical Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Taiwan Taisho Pharmaceutical Recent Developments/Updates
  • 2.10 Yiteng Pharmaceutical
    • 2.10.1 Yiteng Pharmaceutical Details
    • 2.10.2 Yiteng Pharmaceutical Major Business
    • 2.10.3 Yiteng Pharmaceutical Nanobody Drug Product and Services
    • 2.10.4 Yiteng Pharmaceutical Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Yiteng Pharmaceutical Recent Developments/Updates
  • 2.11 Beijing Shuoxing Biotechnology
    • 2.11.1 Beijing Shuoxing Biotechnology Details
    • 2.11.2 Beijing Shuoxing Biotechnology Major Business
    • 2.11.3 Beijing Shuoxing Biotechnology Nanobody Drug Product and Services
    • 2.11.4 Beijing Shuoxing Biotechnology Nanobody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Beijing Shuoxing Biotechnology Recent Developments/Updates

3 Competitive Environment: Nanobody Drug by Manufacturer

  • 3.1 Global Nanobody Drug Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Nanobody Drug Revenue by Manufacturer (2018-2023)
  • 3.3 Global Nanobody Drug Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Nanobody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Nanobody Drug Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Nanobody Drug Manufacturer Market Share in 2022
  • 3.5 Nanobody Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Nanobody Drug Market: Region Footprint
    • 3.5.2 Nanobody Drug Market: Company Product Type Footprint
    • 3.5.3 Nanobody Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nanobody Drug Market Size by Region
    • 4.1.1 Global Nanobody Drug Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Nanobody Drug Consumption Value by Region (2018-2029)
    • 4.1.3 Global Nanobody Drug Average Price by Region (2018-2029)
  • 4.2 North America Nanobody Drug Consumption Value (2018-2029)
  • 4.3 Europe Nanobody Drug Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Nanobody Drug Consumption Value (2018-2029)
  • 4.5 South America Nanobody Drug Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Nanobody Drug Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Nanobody Drug Sales Quantity by Type (2018-2029)
  • 5.2 Global Nanobody Drug Consumption Value by Type (2018-2029)
  • 5.3 Global Nanobody Drug Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Nanobody Drug Sales Quantity by Application (2018-2029)
  • 6.2 Global Nanobody Drug Consumption Value by Application (2018-2029)
  • 6.3 Global Nanobody Drug Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Nanobody Drug Sales Quantity by Type (2018-2029)
  • 7.2 North America Nanobody Drug Sales Quantity by Application (2018-2029)
  • 7.3 North America Nanobody Drug Market Size by Country
    • 7.3.1 North America Nanobody Drug Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Nanobody Drug Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Nanobody Drug Sales Quantity by Type (2018-2029)
  • 8.2 Europe Nanobody Drug Sales Quantity by Application (2018-2029)
  • 8.3 Europe Nanobody Drug Market Size by Country
    • 8.3.1 Europe Nanobody Drug Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Nanobody Drug Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nanobody Drug Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Nanobody Drug Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Nanobody Drug Market Size by Region
    • 9.3.1 Asia-Pacific Nanobody Drug Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Nanobody Drug Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Nanobody Drug Sales Quantity by Type (2018-2029)
  • 10.2 South America Nanobody Drug Sales Quantity by Application (2018-2029)
  • 10.3 South America Nanobody Drug Market Size by Country
    • 10.3.1 South America Nanobody Drug Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Nanobody Drug Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nanobody Drug Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Nanobody Drug Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Nanobody Drug Market Size by Country
    • 11.3.1 Middle East & Africa Nanobody Drug Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Nanobody Drug Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Nanobody Drug Market Drivers
  • 12.2 Nanobody Drug Market Restraints
  • 12.3 Nanobody Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nanobody Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nanobody Drug
  • 13.3 Nanobody Drug Production Process
  • 13.4 Nanobody Drug Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nanobody Drug Typical Distributors
  • 14.3 Nanobody Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nanobody Drug. Industry analysis & Market Report on Nanobody Drug is a syndicated market report, published as Global Nanobody Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Nanobody Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,749.20
    4,123.80
    5,498.40
    3,212.04
    4,818.06
    6,424.08
    524,262.00
    786,393.00
    1,048,524.00
    288,631.20
    432,946.80
    577,262.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report